Mouse corneal lymphangiogenesis model

被引:70
作者
Cao, Renhai [1 ]
Lim, Sharon [1 ]
Ji, Hong [1 ]
Zhang, Yin [1 ]
Yang, Yunlong [1 ]
Honek, Jennifer [1 ]
Hedlund, Eva-Maria [1 ]
Cao, Yihai [1 ,2 ]
机构
[1] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden
[2] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden
基金
欧洲研究理事会; 瑞典研究理事会;
关键词
GROWTH-FACTOR; LYMPHATIC METASTASIS; GENETIC-HETEROGENEITY; PDGF-BB; IN-VIVO; VEGF-C; ANGIOGENESIS; PERMEABILITY; RECEPTOR-3; STRAINS;
D O I
10.1038/nprot.2011.359
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
This protocol describes a powerful in vivo method to quantitatively study the formation of new lymphatic vessels in the avascular cornea without interference of pre-existing lymphatics. Implantation of 100 ng of lymphangiogenic factors such as vascular endothelial growth factor (VEGF)-A, VEGF-C or fibroblast growth factor-2, together with slow-release polymers, into a surgically created micropocket in the mouse cornea elicits a robust lymphangiogenic response. Newly formed lymphatic vessels are detected by immunohistochemical staining of the flattened corneal tissue with lymphatic endothelial-specific markers such as lymphatic vessel endothelial hyaluronan receptor-1; less-specific markers such as vascular endothelial growth factor receptor 3 may also be used. Lymphatic vessel growth in relation to hemangiogenesis can be readily detected starting at day 5 or 6 after pellet implantation and persists for similar to 14 d. This protocol offers a unique opportunity to study the mechanisms underlying lymphatic vessel formation, remodeling and function.
引用
收藏
页码:817 / 826
页数:10
相关论文
共 24 条
[1]
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth [J].
Albuquerque, Romulo J. C. ;
Hayashi, Takahiko ;
Cho, Won Gil ;
Kleinman, Mark E. ;
Dridi, Sami ;
Takeda, Atsunobu ;
Baffi, Judit Z. ;
Yamada, Kiyoshi ;
Kaneko, Hiroki ;
Green, Martha G. ;
Chappell, Joe ;
Wilting, Joerg ;
Weich, Herbert A. ;
Yamagami, Satoru ;
Amano, Shiro ;
Mizuki, Nobuhisa ;
Alexander, Jonathan S. ;
Peterson, Martha L. ;
Brekken, Rolf A. ;
Hirashima, Masanori ;
Capoor, Seema ;
Usui, Tomohiko ;
Ambati, Balamurali K. ;
Ambati, Jayakrishna .
NATURE MEDICINE, 2009, 15 (09) :1023-U74
[2]
Lymphangiogenesis in development and human disease [J].
Alitalo, K ;
Tammela, T ;
Petrova, TV .
NATURE, 2005, 438 (7070) :946-953
[3]
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo [J].
Björndahl, M ;
Cao, RH ;
Nissen, LJ ;
Clasper, S ;
Johnson, LA ;
Xue, Y ;
Zhou, ZJ ;
Jackson, D ;
Hansen, AJ ;
Cao, YH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (43) :15593-15598
[4]
Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis [J].
Björndahl, MA ;
Cao, R ;
Burton, JB ;
Brakenhielm, E ;
Religa, P ;
Galter, D ;
Wu, L ;
Cao, YH .
CANCER RESEARCH, 2005, 65 (20) :9261-9268
[5]
Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts [J].
Bock, F. ;
Onderka, J. ;
Hos, D. ;
Horn, F. ;
Martus, P. ;
Cursiefen, C. .
EXPERIMENTAL EYE RESEARCH, 2008, 87 (05) :462-470
[6]
Bruyère F, 2008, NAT METHODS, V5, P431, DOI [10.1038/nmeth.1205, 10.1038/NMETH.1205]
[7]
PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis [J].
Cao, RH ;
Björndahl, MA ;
Religa, P ;
Clasper, S ;
Garvin, S ;
Galter, D ;
Meister, B ;
Ikomi, F ;
Tritsaris, K ;
Dissing, S ;
Ohhashi, T ;
Jackson, DG ;
Cao, YH .
CANCER CELL, 2004, 6 (04) :333-345
[8]
Hepatocyte growth factor is a lymphanoiogenic factor with an indirect mechanism of action [J].
Cao, RH ;
Björndahl, MA ;
Gallego, MI ;
Chen, SH ;
Religa, P ;
Hansen, AJ ;
Cao, YH .
BLOOD, 2006, 107 (09) :3531-3536
[9]
Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2 [J].
Cao, RH ;
Bråkenhielm, E ;
Pawliuk, R ;
Wariaro, D ;
Post, MJ ;
Wahlberg, E ;
Leboulch, P ;
Cao, YH .
NATURE MEDICINE, 2003, 9 (05) :604-613
[10]
Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability [J].
Cao, RH ;
Eriksson, A ;
Kubo, H ;
Alitalo, K ;
Cao, YH ;
Thyberg, J .
CIRCULATION RESEARCH, 2004, 94 (05) :664-670